Medigene

Immunocore is the latest to nab a private placement, securing $140M to pursue more TCR R&D
Endpoints
Mon, 07/18/22 - 07:13 pm
Immunocore
R&D
PIPE financing
Medigene
tebentafusp
BioNTech and Medigene team up on T cell immunotherapy
Biopharma Reporter
Tue, 02/22/22 - 11:10 pm
BioNTech
Medigene
T-cell immunotherapy
oncology
Bluebird widens hunt for TCR therapies in revised Medigene deal
Biopharma Dive
Mon, 05/14/18 - 10:58 pm
Bluebird Bio
Medigene
CAR-T